‹ All Posts
Kundan Motwani

25th Mar · SEBI-Registered Analyst

AUROBINDO PHARMA:

AUROBINDO PHARMA: CO SUBSIDIARY CURATEQ BIOLOGICS ENTERS MARKETING AND DISTRIBUTION AGREEMENT WITH STADA ARZNEIMITTEL AG

AUROPHARMA

#StockInNews#WatchOutFor
573 likes·23 comments